Nutraceutical productions from microalgal derived compounds via circular bioeconomy perspective

Abstract

Circular bioeconomy has become a sustainable business model for commercial production that promises to reuse, recycle & recover while considering less environmental footprints in nutraceutical industries. Microalgae biotechnology has the synergy to bioremediate waste stream while generating high-value-added compounds such as astaxanthin, protein and polyunsaturated fatty acids that are potential compounds used in various industries, thus, the integration of this approach provides economic advantages. However, since the industrial production of these compounds is costly and affected by unstable climate in the Nordic regions such as low temperature, light intensity, and polar circle, the focus of biosynthesis has shifted from less tolerant commercial strains towards indigenous strains. Nutraceutical productions such as polyunsaturated fatty acids and protein can now be synthesized at low temperatures which significantly improve the industry's economy. In this review, the above-mentioned compounds with potential strains were discussed based on a Nordic region’s perspective.